Schedule 13D ownership disclosure
Asterias Biotherapeutics, Inc.
Security class unavailable · CUSIP: 04624N107
Event date: 2017-11-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 21,747,569
- Percent of class
- 40.1600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-17-013369
- Form type
- SC 13D
- Filer
- Asterias Biotherapeutics, Inc.
- CIK
- CIK 1572552
- Filed
- Nov 15, 2017
- Reporting period
- Nov 14, 2017
- Description
- Schedule 13D beneficial ownership